CLINICAL_TRIALS
research
· 2025-12-12
Clinical Trial Update: Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS) [Phase 1, Phase 2]
Summary
This update describes a Phase 1/2 trial evaluating rifapentine plus isoniazid (3HP) as TB preventive therapy for children on dolutegravir-based antiretroviral t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Aurum Institute NPC | Conditions: Tuberculosis, HIV | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING